3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
34
Carcinoma, Non-Small-Cell Lung
22
Carcinoma, Renal Cell
20
Neoplasm Metastasis
13
Carcinoma, Hepatocellular
10
Brain Neoplasms
8
Lung Neoplasms
7
Skin Neoplasms
6
Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Kidney Neoplasms
5
Clear-cell metastatic renal cell carcinoma
5
Carcinoma, Transitional Cell
5
Uveal Melanoma
4
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Glioblastoma
4
Carcinoma, Basal Cell
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma
3
Recurrence
3
Mesothelioma
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Histiocytoma, Malignant Fibrous
3
Interventions
asciminib
15
Cyclophosphamide
12
fludarabine phosphate
10
Mycophenolic Acid
9
fludarabine
8
nilotinib
7
Whole-Body Irradiation
7
Imatinib Mesylate
6
Dasatinib
6
Tacrolimus
5
Sirolimus
5
Cyclosporine
5
venetoclax
4
bosutinib
4
Melphalan
4
Granulocyte Colony-Stimulating Factor
4
ponatinib
3
Thiotepa
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporins
3
Busulfan
3
thymoglobulin
2
ruxolitinib
2
Specimen Handling
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
Blood Component Removal
2
treosulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Ipilimumab
×
90 days
×
Clear all
No trials found.